944388-73-2Relevant academic research and scientific papers
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors
Cai, Jiaqiang,Baugh, Mark,Black, Darcey,Long, Clive,Jonathan Bennett,Dempster, Maureen,Fradera, Xavier,Gillespie, Jonathan,Andrews, Fiona,Boucharens, Sylviane,Bruin, John,Cameron, Kenneth S.,Cumming, Iain,Hamilton, William,Jones, Philip S.,Kaptein, Allard,Kinghorn, Emma,Maidment, Maurice,Martin, Iain,Mitchell, Ann,Rankovic, Zoran,Robinson, John,Scullion, Paul,Uitdehaag, Joost C.M.,Vink, Paul,Westwood, Paul,Van Zeeland, Mario,Van Berkom, Leon,Bastiani, Martijn,Meulemans, Tommi
scheme or table, p. 4350 - 4354 (2010/09/11)
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile analogues were identified as potent and selective cathepsin S inhibitor against both purified enzyme and in human JY cell based cellular assays. This core has a very stable thio-trapping nitrile war-head in comparison with the well reported pyrimidine-2-carbonitrile cysteine cathepsin inhibitors. Compound 47 is also very potent in in vivo mouse spleenic Lip10 accumulation assays.
6-PHENYL-1H-IMIDAZO[4, 5-C]PYRIDINE-4-CARBONITRILE DERIVATIVES AS CATHEPSIN K AND S INHIBITORS
-
Page/Page column 15-16, (2010/11/28)
The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula (I), to pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S and/or cathepsin K related diseases such as osteoporosis, atherosclerosis, inflammation and immune disorders, such as rheumatoid arthritis, and chronic pain, such as neuropathic pain.
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
-
Page/Page column 9, (2010/11/28)
The present invention relates to 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives having the general Formula I wherein each of the substituents is given the definition as set forth in the specification and claims, pharmaceutical compositions comprising the same as well as to the use of these derivatives for the preparation of a medicament for the treatment of cathepsin S and/or cathepsin K related diseases such as osteoporosis, atherosclerosis, inflammation and immune disorders, such as rheumatoid arthritis, and chronic pain, such as neuropathic pain.
